Quality indicators of asthma care
| Quality indicators | Standard target (%) | n (%) |
|---|---|---|
| Indicators for an audit of the process (N=433) | ||
| Documentation of asthma control status | 80 | 188 (43.4) |
| Documentation of all asthma indicators | 80 | 56 (12.9) |
| –Documentation of daytime symptoms | 80 | 148 (34.2) |
| –Documentation of night waking due to asthma | 80 | 127 (29.3) |
| –Documentation of the use of reliever | 80 | 151 (34.9) |
| –Documentation of activity limitation due to asthma | 80 | 85 (19.6) |
| Documentation of AEBA since the last visit | 80 | 130 (30.0) |
| Documentation of treatment adherence | 80 | 171 (39.5) |
| Documentation of PEFR measurement | 80 | 89 (20.6) |
| Documentation of inhaler technique assessment | 80 | 30 (6.9) |
| Indicators for audit of structure (N=24) | ||
| Peak flow metre | 80 | 16 (66.7) |
| Reference chart for PEFR readings | 80 | 18 (75.0) |
| Printed patient educational material | 80 | 1 (4.2) |
| Published asthma guideline | 80 | 1 (4.2) |
| Spacer for inhaler | 80 | 0 (0.0) |
| Placebo inhaler | 80 | 0 (0.0) |
| Indicators for audit of outcome | ||
| Proportion of asthma patients prescribed with inhaled SABA (N=433) | 100 | 358 (82.7) |
| Proportion of patients with poorly controlled asthma prescribed with inhaled preventer (N=59) | 100 | 53 (89.8) |
| Quality indicators | Standard target (%) | |
|---|---|---|
| Indicators for an audit of the process ( | ||
| Documentation of asthma control status | 80 | 188 (43.4) |
| Documentation of all asthma indicators | 80 | 56 (12.9) |
| –Documentation of daytime symptoms | 80 | 148 (34.2) |
| –Documentation of night waking due to asthma | 80 | 127 (29.3) |
| –Documentation of the use of reliever | 80 | 151 (34.9) |
| –Documentation of activity limitation due to asthma | 80 | 85 (19.6) |
| Documentation of AEBA since the last visit | 80 | 130 (30.0) |
| Documentation of treatment adherence | 80 | 171 (39.5) |
| Documentation of PEFR measurement | 80 | 89 (20.6) |
| Documentation of inhaler technique assessment | 80 | 30 (6.9) |
| Indicators for audit of structure ( | ||
| Peak flow metre | 80 | 16 (66.7) |
| Reference chart for PEFR readings | 80 | 18 (75.0) |
| Printed patient educational material | 80 | 1 (4.2) |
| Published asthma guideline | 80 | 1 (4.2) |
| Spacer for inhaler | 80 | 0 (0.0) |
| Placebo inhaler | 80 | 0 (0.0) |
| Indicators for audit of outcome | ||
| Proportion of asthma patients prescribed with inhaled SABA ( | 100 | 358 (82.7) |
| Proportion of patients with poorly controlled asthma prescribed with inhaled preventer ( | 100 | 53 (89.8) |
Notes: AEBA, acute exacerbation of bronchial asthma; PEFR, peak expiratory flow rate; SABA, short-acting β agonist
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.